Reference:
- De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet.
2016;388(10047):906-18.
- Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer
CA, et al. Serum TSH, T4, and thyroid antibodies in the United States
population (1988 to 1994): National Health and Nutrition Examination
Survey (NHANES III). J Clin Endo Metab. 2002;87:489–99.
- Devereaux D, Tewelde SZ. Hyperthyroidism and thyrotoxicosis. Emerg Med
Clin North Am. 2014; 32:277–92.
- Leung AM, Braverman LE. Iodine-induced thyroid dysfunction. Curr Opin
Endocrinol Diabetes Obes. 2012;19(5):414-9.
- Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid
iodide transporter. Nature. 1996;379(6564):458-60.
- Bizhanova A, Kopp P. Minireview: the sodium-iodide symporter NIS and
pendrin in iodide homeostasis of the thyroid. Endocrinology.
2009;150(3):1084-90.
- Dunne P, Kaimal N, MacDonald J, Syed AA. Iodinated contrast-induced
thyrotoxicosis. CMAJ. 2013;185(2):144-7
- Zimmermann MB. Iodine deficiency. Endocr Rev. 2009;30:376–408
- Lee SY, Rhee CM, Leung AM, Braverman LE, Brent GA, Pearce EN. A
review: Radiographic iodinated contrast media-induced thyroid
dysfunction. J Clin Endocrinol Metab. 2015;100(2):376-83.
- Wu SY, Leung AM, Chambers MD, Chen CL, Khan MU, Brent GA, et al.
Coexistent presentation of Graves’ disease and an autonomous thyroid
nodule following administration of an iodinated contrast load. Journal
of Clinical and Translational Endocrinology: Case Reports 2018.
- Phillips BD, Hennessey JV. Iodinated contrast prior to evaluation for
thyrotoxicosis. J Hosp Med. 2009;4(5):285-8.
- Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm.
Endocrinol Metab Clin North Am. 1993;22:263–77.